Thermo Fisher Scientific Inc
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Marc N. Casper
- Full Time Employees
- 125,000
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- 168 Third Avenue Waltham MA United States 02451
- IPO Date
- Aug 27, 1980
- CIK
- 0000097745
- Website
- corporate.thermofisher.com
- Similar Companies
- Business
- Thermo Fisher Scientific Inc. (NYSE: TMO) provides analytical instruments, equipment, software, services, consumables, and reagents for research, analysis, discovery, and diagnostics worldwide. The company offers products including mass spectrometry systems, chromatography instruments, genetic analysis tools, bioprocessing equipment, clinical diagnostics assays, laboratory automation solutions, and electron microscopy technologies; its key brands encompass Thermo Scientific, Invitrogen, Fisher Scientific, Unity Lab Services, and Patheon. Headquartered in Waltham, Massachusetts, Thermo Fisher was originally founded in 1902 through the merger of Fisher Scientific and Thermo Electron in 2006, and operates in over 70 countries serving pharmaceutical, biotechnology, academic, government, and healthcare customers across life sciences, analytical technologies, specialty diagnostics, and laboratory products segments. Recently, the company expanded its capabilities through the acquisition of Olink Holding AB in 2024 to bolster proteomics offerings, launched the new Orbitrap Astral mass spectrometer in late 2024 for high-throughput proteomics, and formed strategic partnerships including a multi-year collaboration with AstraZeneca to advance biomarker discovery; in 2025, Thermo Fisher announced expansions in gene editing technologies and sustainable manufacturing initiatives amid ongoing supply chain optimizations.
Company News
Thermo Fisher: You Don't Need A Microscope To See The Growth Anymore
Thermo Fisher Scientific: 3 Key Takeaways for Long-Term Investors
Thermo Fisher Stocks Rise 1.0% as Revenue Growth Beats Estimates
Nasdaq Gains 1%; Thermo Fisher Scientific Posts Upbeat Earnings
Thermo Fisher Scientific Inc. (TMO) Q3 2026 Earnings Call Transcript
TMO Q3 Earnings & Revenues Beat Estimates, Stock Down in Pre-Market
Compared to Estimates, Thermo Fisher (TMO) Q3 Earnings: A Look at Key Metrics
Thermo Fisher Q3: The Recovery Is Real, And I'm Still Buying
Thermo Fisher Scientific Q3 Earnings Call Highlights
Thermo Fisher posts higher third-quarter revenue and earnings as margins improve
Thermo Fisher Scientific (TMO) Tops Q3 Earnings and Revenue Estimates
Thermo Fisher Scientific Reports Third Quarter 2026 Results
Why Thermo Fisher (TMO) Could Beat Earnings Estimates Again
Top Wall Street Forecasters Revamp Thermo Fisher Scientific Expectations Ahead Of Q3 Earnings
Two stocks poised to benefit from rotation out of AI
TMO DCF Analysis: Intrinsic Value $421 vs Price $690
Banque Pictet & Cie SA Sells 6,618 Shares of Thermo Fisher Scientific Inc. $TMO
What Analyst Projections for Key Metrics Reveal About Thermo Fisher (TMO) Q3 Earnings
Pfizer, Thermo Fisher Scientific And More: CNBC's ‘Final Trades'
Thermo Fisher Scientific (TMO) Reports Next Week: Wall Street Expects Earnings Growth